期刊
DEVELOPMENTAL CELL
卷 36, 期 3, 页码 303-315出版社
CELL PRESS
DOI: 10.1016/j.devcel.2015.12.031
关键词
-
资金
- NIH [HL110942]
- Penn Diabetes Center Transgenic Core [NIH P30 DK19525, NIH R37 DK43806]
- AHA fellowship [11PRE7580096]
The terminal stages of pulmonary development, called sacculation and alveologenesis, involve both differentiation of distal lung endoderm progenitors and extensive cellular remodeling of the resultant epithelial lineages. These processes are coupled with dramatic expansion of distal airspace and surface area. Despite the importance of these late developmental processes and their relation to neonatal respiratory diseases, little is understood about the molecular and cellular pathways critical for their successful completion. We show that a histone deacetylase 3 (Hdac3)-mediated epigenetic pathway is critical for the proper remodeling and expansion of the distal lung saccules into primitive alveoli. Loss of Hdac3 in the developing lung epithelium leads to a reduction of alveolar type 1 cell spreading and a disruption of lung sacculation. Hdac3 represses miR-17-92 expression, a microRNA cluster that regulates transforming growth factor beta (TGF-beta) signaling. De-repression of miR-17-92 in Hdac3-deficient lung epithelium results in decreased TGF-beta signaling activity. Importantly, inhibition of TGF-beta signaling and overexpression of miR-17-92 can phenocopy the defects observed in Hdac3 null lungs. Conversely, loss of miR-17-92 expression rescues many of the defects caused by loss of Hdac3 in the lung. These studies reveal an intricate epigenetic pathway where Hdac3 is required to repress miR-17-92 expression to allow for proper TGF-beta signaling during lung sacculation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据